Euronext N.V.

Regulatory Filings • Feb 9, 2009

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for January 2009

Feb. 9, 2009 – NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for January 20091 .

Cash Trading

U.S. cash products handled average daily volume ("ADV") decreased 8.9% to 3.5 billion shares2 .

• Total NYSE-listed (Tape A) consolidated volume increased 8.3% to 5.4 billion shares.
• NYSE-listed matched volume (Tape A) decreased 13.8% to 2.3 billion shares.
• Tape A matched market share was 42.3%, compared to 43.4% in December 2008 and 58.4% in January 2008.
• Designated Market Maker (DMM) participation in January 2009 was 8.4%, the highest level of participation since February 2006, and up from 7% in December 2008. The increased level of participation was driven in part by the introduction of the NYSE's new market model in October 2008.
• Total NYSE Arca and NYSE Amex-listed consolidated volume (Tape B) increased 60.4% to 2.0 billion shares.
• NYSE's matched volume of Tape B increased 38.4% to 540 million shares.
• Total Nasdaq-listed (Tape C) consolidated volume decreased 23.8% to 2.1 billion shares.
• NYSE's matched volume of Tape C decreased 26.6% to 324 million shares.
• Tape C matched market share was relatively stable at 15.8%, compared to 15.6% in December 2008 and 16.4% in January 2008.
• Exchange-traded funds matched volume (included in the trading volume numbers above) increased 24.8% to 535 million shares.

European cash products ADV decreased 29.5% to 1.3 million transactions2 from 1.9 million transactions in January 2008, which was the second highest monthly ADV in 2008.

• European cash trading activity qualifying for Pack Epsilon pricing represented 35% of total transactions executed.

¹ All comparisons versus January 2008 unless otherwise stated. ²

Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.

Derivatives Trading

European derivatives products ADV was 3.8 million futures and options contracts, a decrease of 18.4% from January 2008, primarily driven by a decline in interest rate trading volume.

• Total interest rate products ADV decreased 32.1% to 2.0 million contracts from 2.9 million contracts in January 2008, which was the highest monthly ADV ever for interest rate products.
• Total equity products (including Bclear) ADV increased 5.6% to 1.8 million contracts. Bclear, NYSE Liffe's trade administration and clearing service, processed 779 thousand contracts per day, an increase of 98.2%.

U.S. equity options ADV decreased 13.7% to 2.1 million contracts. Total consolidated options ADV declined 23.5% to 12.0 million contracts. NYSE Euronext's U.S. options exchanges (NYSE Arca and NYSE Amex) accounted for 17.4% of the total consolidated equity options trading in January, up from 15.4% in January 2008.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is the world's leading, most liquid and diverse exchange group. It offers a broad and growing array of financial products and services in cash equities, futures, options, exchange-traded products, bonds, market data, and commercial technology solutions, all designed to meet the evolving needs of issuers, investors and financial institutions. Spanning multiple asset classes and six countries, NYSE Euronext's exchanges include the New York Stock Exchange, Liffe, Euronext and NYSE Arca. With more than 6,500 listed issues, more than any other exchange group, trading on NYSE Euronext's equity markets represents more than one-third of the world's cash equities volume. NYSE Euronext also manages the leading European derivatives exchange by value of trading. NYSE Euronext is part of the S&P 500 index and the only exchange operator in the S&P 100 index. For more information, please visit www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2007 ("document de référence") filed with the French Autorité des Marchés Financiers (Registered on May 15, 2008 under No. R. 08-054), 2007 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

NYSE Euronext Monthly Volume Summary - Cash Products

	Average Daily Volume			Total Volume			Total Volume
								% Chg vs.
(Unaudited)	Jan-09	Jan-08	% Chg	Jan-09	Jan-08	% Chg	YTD 2009	YTD 2008
Number of Trading Days - European Markets	21	22		21	22		21
Number of Trading Days - U.S. Markets	20	21		20	21		20
European Cash Products (trades in thousands)	1,329	1,886	-29.5%	27,918	41,501	-32.7%	27,918	-32.7%
Equities	1,264		1,821 -30.6%	26,542		40,052 -33.7%	26,542	-33.7%
Exchange-Traded Funds Structured Products	13 47	11 48	16.2% -2.1%	275 996	248 1,065	10.9% -6.5%	275 996	10.9% -6.5%
Bonds	5		6 -18.8%	106		137 -22.5%	106	-22.5%
U.S. Cash Products (shares in millions) 2	3,540	3,885	-8.9%	70,790	81,580	-13.2%	70,790	-13.2%
NYSE Listed (Tape A) Issues 1
NYSE Group Handled Volume 2	2,520	2,894	-12.9%	50,390	60,780	-17.1%	50,390	-17.1%
NYSE Group Matched Volume 3	2,271	2,634	-13.8%	45,430	55,311	-17.9%	45,430	-17.9%
NYSE Group TRF Volume 4	9	208	-95.6%	184	4,359	-95.8%	184	-95.8%
Total NYSE Listed Consolidated Volume	5,370	4,959	8.3%	107,394	104,149	3.1%	107,394	3.1%
NYSE Group Share of Total Consolidated Volume
Handled Volume 2	46.9%	58.4%	-11.5%	46.9%	58.4%	-11.5%	46.9%	-11.5%
Matched Volume 3	42.3%	53.1%	-10.8%	42.3%	53.1%	-10.8%	42.3%	-10.8%
TRF Volume 4	0.2%	4.2%	-4.0%	0.2%	4.2%	-4.0%	0.2%	-4.0%
NYSE Arca & Alternext US (Tape B) Listed Issues
NYSE Group Handled Volume 2	622	454	37.0%	12,445	9,540	30.4%	12,445	30.4%
NYSE Group Matched Volume 3	540	390	38.4%	10,802	8,197	31.8%	10,802	31.8%
NYSE Group TRF Volume 4 Total NYSE Arca & Amex Listed Consolidated Volume	1 2,037	85 1,269	-98.8% 60.4%	21 40,736	1,788 26,658	-98.8% 52.8%	21 40,736	-98.8% 52.8%
NYSE Group Share of Total Consolidated Volume
Handled Volume 2	30.6%	35.8%	-5.2%	30.6%	35.8%	-5.2%	30.6%	-5.2%
Matched Volume 3	26.5%	30.7%	-4.2%	26.5%	30.7%	-4.2%	26.5%	-4.2%
TRF Volume 4	0.1%	6.7%	-6.6%	0.1%	6.7%	-6.6%	0.1%	-6.6%
Nasdaq Listed (Tape C) Issues
NYSE Group Handled Volume 2	398	536	-25.8%	7,955	11,260	-29.3%	7,955	-29.3%
NYSE Group Matched Volume 3	324	441	-26.6%	6,474	9,257	-30.1%	6,474	-30.1%
NYSE Group TRF Volume 4 Total Nasdaq Listed Consolidated Volume	7 2,051	203 2,691	-96.4% -23.8%	148 41,011	4,257 56,502	-96.5% -27.4%	148 41,011	-96.5% -27.4%
NYSE Group Share of Total Consolidated Volume
Handled Volume 2	19.4%	19.9%	-0.5%	19.4%	19.9%	-0.5%	19.4%	-0.5%
Matched Volume 3	15.8%	16.4%	-0.6%	15.8%	16.4%	-0.6%	15.8%	-0.6%
TRF Volume 4	0.4%	7.5%	-7.1%	0.4%	7.5%	-7.1%	0.4%	-7.1%
Exchange-Traded Funds 1,5
NYSE Group Handled Volume 2	617	497	24.2%	12,339	10,430	18.3%	12,339	18.3%
NYSE Group Matched Volume 3	535	429	24.8%	10,708	9,010	18.8%	10,708	18.8%
NYSE Group TRF Volume 4	1	104	-99.3%	15	2,178	-99.3%	15	-99.3%
Total ETF Consolidated Volume	2,060	1,391	48.1%	41,195	29,215	41.0%	41,195	41.0%
NYSE Group Share of Total Consolidated Volume
Handled Volume 2	30.0%	35.7%	-5.7%	30.0%	35.7%	-5.7%	30.0%	-5.8%
Matched Volume 3	26.0%	30.8%	-4.8%	26.0%	30.8%	-4.8%	26.0%	-4.8%
TRF Volume 4	0.0%	7.5%	-7.5%	0.0%	7.5%	-7.5%	0.0%	-7.5%

NYSE Euronext Monthly Volume Summary - Derivatives Products

	Average Daily Volume			Total Volume			Total Volume
(Unaudited; contracts in thousands)	Jan-09	Jan-08	% Chg	Jan-09	Jan-08	% Chg	YTD 2009	% Chg vs. YTD 2008
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	21 20	22 21		21 20	22 21		21 20
European Derivatives Products	3,826	4,691	-18.4%	80,349	103,192	-22.1%	80,349	-22.1%
Total Interest Rate Products 6	1,989	2,927	-32.1%	41,760	64,399	-35.2%	41,760	-35.2%
Short Term Interest Rate Products Medium and Long Term Interest Rate Products	1,911 78	2,829 98	-32.5% -20.9%	40,127 1,633	62,235 2,164	-35.5% -24.5%	40,127 1,633	-35.5% -24.5%
Total Equity Products 7	1,793	1,698	5.6%	37,655	37,357	0.8%	37,655	0.8%
Individual Equity Products Equity Index Products	1,196 597	894 804	33.8% -25.8%	25,124 12,532	19,673 17,684	27.7% -29.1%	25,124 12,532	27.7% -29.1%
of which Bclear Individual Equity Products Equity Index Products	779 650 129	393 268 125	98.2% 142.6% 3.2%	16,363 13,653 2,711	8,647 5,895 2,752	89.2% 131.6% -1.5%	16,363 13,653 2,711	89.2% 131.6% -1.5%
Commodity Products	44	65	-31.8%	934	1,436	-34.9%	934	-34.9%
U.S. Derivatives Products
U.S. Derivatives Products - Equity Options 8
NYSE Group Options Contracts Total Consolidated Options Contracts	2,086 11,974	2,418 15,656	-13.7% -23.5%	41,725 239,490	50,786 328,781	-17.8% -27.2%	41,725 239,490	-17.8% -27.2%
NYSE Group Share of Total	17.4%	15.4%		17.4%	15.4%		17.4%	2.0%

1 Includes all volume executed in NYSE Group crossing sessions.

2 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to

and executed at an external market center. NYSE Arca routing includes odd-lots.

3 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

4 Represents NYSE's volume in FINRA/NYSE Trade Reporting Facility (TRF).

5 Data included in previously identified categories.

6 Data includes currency products.

7 Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives.

8 Includes trading in U.S. equity options contracts, not equity-index options.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. US Equities data has been updated for Amex integration for October 2008 forward.